» Articles » PMID: 24338009

The Interaction of Integrin αIIbβ3 with Fibrin Occurs Through Multiple Binding Sites in the αIIb β-propeller Domain

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2013 Dec 17
PMID 24338009
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

The currently available antithrombotic agents target the interaction of platelet integrin αIIbβ3 (GPIIb-IIIa) with fibrinogen during platelet aggregation. Platelets also bind fibrin formed early during thrombus growth. It was proposed that inhibition of platelet-fibrin interactions may be a necessary and important property of αIIbβ3 antagonists; however, the mechanisms by which αIIbβ3 binds fibrin are uncertain. We have previously identified the γ370-381 sequence (P3) in the γC domain of fibrinogen as the fibrin-specific binding site for αIIbβ3 involved in platelet adhesion and platelet-mediated fibrin clot retraction. In the present study, we have demonstrated that P3 can bind to several discontinuous segments within the αIIb β-propeller domain of αIIbβ3 enriched with negatively charged and aromatic residues. By screening peptide libraries spanning the sequence of the αIIb β-propeller, several sequences were identified as candidate contact sites for P3. Synthetic peptides duplicating these segments inhibited platelet adhesion and clot retraction but not platelet aggregation, supporting the role of these regions in fibrin recognition. Mutant αIIbβ3 receptors in which residues identified as critical for P3 binding were substituted for homologous residues in the I-less integrin αMβ2 exhibited reduced cell adhesion and clot retraction. These residues are different from those that are involved in the coordination of the fibrinogen γ404-411 sequence and from auxiliary sites implicated in binding of soluble fibrinogen. These results map the binding of fibrin to multiple sites in the αIIb β-propeller and further indicate that recognition specificity of αIIbβ3 for fibrin differs from that for soluble fibrinogen.

Citing Articles

[Pedigree Analysis and Molecular Mechanism Study of Hereditary Glanzmann Thrombasthenia Caused by Compound Heterozygous Mutation of the ITGA2B Gene].

Lu X, Fu D, Zhang Y, Zhao L, Wang L, Yang J Zhonghua Xue Ye Xue Za Zhi. 2024; 45(4):370-377.

PMID: 38951065 PMC: 11168003. DOI: 10.3760/cma.j.cn121090-20230816-00070.


Systematic mapping of the conformational landscape and dynamism of soluble fibrinogen.

Pinelo J, Manandhar P, Popovic G, Ray K, Tasdelen M, Nguyen Q J Thromb Haemost. 2023; 21(6):1529-1543.

PMID: 36746319 PMC: 10407912. DOI: 10.1016/j.jtha.2023.01.034.


Advantages of Fibrin Polymerization Method without the Use of Exogenous Thrombin for Vascular Tissue Engineering Applications.

Matveeva V, Senokosova E, Sevostianova V, Khanova M, Glushkova T, Akentieva T Biomedicines. 2022; 10(4).

PMID: 35453539 PMC: 9026760. DOI: 10.3390/biomedicines10040789.


The P2Y12 Receptor Antagonist Selatogrel Dissolves Preformed Platelet Thrombi In Vivo.

Crescence L, Kramberg M, Baumann M, Rey M, Roux S, Panicot-Dubois L J Clin Med. 2021; 10(22).

PMID: 34830631 PMC: 8619398. DOI: 10.3390/jcm10225349.


Platelet binding to polymerizing fibrin is avidity driven and requires activated αIIbβ3 but not fibrin cross-linking.

Buitrago L, Lefkowitz S, Bentur O, Padovan J, Coller B Blood Adv. 2021; 5(20):3986-4002.

PMID: 34647980 PMC: 8945615. DOI: 10.1182/bloodadvances.2021005142.


References
1.
SKAER R, Emmines J, Skaer H . The fine structure of cell contacts in platelet aggregation. J Ultrastruct Res. 1979; 69(1):28-42. DOI: 10.1016/s0022-5320(79)80040-4. View

2.
Hayashi T, Mogami H, Murakami Y, Nakamura T, Kanayama N, Konno H . Real-time analysis of platelet aggregation and procoagulant activity during thrombus formation in vivo. Pflugers Arch. 2008; 456(6):1239-51. DOI: 10.1007/s00424-008-0466-9. View

3.
Mustard J, Packham M, Kinlough-Rathbone R, Perry D, REGOECZI E . Fibrinogen and ADP-induced platelet aggregation. Blood. 1978; 52(2):453-66. View

4.
Bennett J . Platelet-fibrinogen interactions. Ann N Y Acad Sci. 2001; 936:340-54. DOI: 10.1111/j.1749-6632.2001.tb03521.x. View

5.
Lishko V, Kudryk B, Yakubenko V, Yee V, Ugarova T . Regulated unmasking of the cryptic binding site for integrin alpha M beta 2 in the gamma C-domain of fibrinogen. Biochemistry. 2002; 41(43):12942-51. DOI: 10.1021/bi026324c. View